ABSTRACT Tumor invasion is the outcome of a complex interplay between cancer cells and the stromal environment. Considering the contribution of the stromal environment, we developed a membrane-free single-cell and spheroid based complementary model to study cancer invasion through native collagen type-I matrices. Cell morphology is preserved during the assays allowing real time monitoring of invasion-induced changes in cell structure and F-actin organization. Combining these models with computerized quantification permits the calculation of highly reproducible and operator-independent data. These assays are versatile in the use of fluorescent probes and have a flexible kinetic endpoint. Once the optimal experimental conditions are empirically determined, the collagen type-I invasion assays can be used for preclinical validation of small-molecule inhibitors targeting invasion. Initiation and monitoring of the single-cell and spheroid invasion model can be achieved in 8 h (over 3 days) and in 14 h (over 8 days) respectively.
Introduction
Emergence of the invasive behavior during cancer progression is a critical feature of malignancy. Several classes of proteins involved in the tethering of cells to their surroundings in a tissue are altered in cells possessing invasive capabilities. The affected proteins include cell-cell adhesion molecules such as members of the calcium-dependent cadherin families, and integrins, which link cells to extracellular matrix substrates. However, molecular and cellular research focused on cancer cells themselves appear to be inadequate since several tumor cell populations including myofibroblasts, bone marrow-derived mesenchymal stem cells, immune and endothelial cells become resident within clinical tumors De Wever et al., 2008) . Indeed, according to the multifactorial nature of the malignant transformation, it is generally well accepted that cancer invasion is the outcome of a complex interplay between cancer cells and the host tissue environment in solid tumors (Hanahan and Weinberg, 2000) . In vitro modeling is appropriate for dissecting various mechanisms involved in cancer cell invasion and stromal cell 1991; Wolf et al., 2003) are frequently used as ECM substrates in invasion assays. The ideal model would allow for easy manipulation, quantification by digital analysis, morphotypic and morphometric studies, further downstream biochemical assays, and close recapitulation of the in vivo situation (Bruyère et al., 2008) .
The models presented in the present protocol, are based on the preparation of a native collagen type I gel, the main interstitial matrix component in solid tumors, in which the addition of test cell populations either as single-cells on top of the collagen or as cellular spheroid aggregates inside the collagen is varied. The use of multicellular spheroid aggregates allow us to gain insight into therapeutic problems associated with metabolic and proliferative gradients, such as the altered responsiveness and effects of chronically hypoxic tumor cells, and the importance of 3D cellcell and cell-matrix interactions in radio-and chemoresistance (Friedrich et al., 2009) . With the increasingly recognized fact that gene signatures from the stromal environment are critical parameters for tumor progression and clinical outcome (Finak et al., 2008) , we need to develop original models to test how stromalderived structural and biochemical cues drive invasive cancer growth. In the heterotypic spheroid invasion model, the tumor environment is represented by stromal myofibroblasts. During the time course of the assay cell morphology is preserved in the matrix, allowing biochemical analysis and real-time monitoring to acquire important insights into basic features of the invasive migratory process. In a next step, computer-generated binary images allow the calculation of highly reproducible and operatorindependent data, such as the invasion area and morphometry. This protocol or parts of this protocol have been used successfully by us and others in the past (Behrens et al., 1993; De Wever et al., 2004a; 2004b; Fritah et al., 2008; Grijelmo et al., 2007; Meerschaert et al., 2007; Mooradian et al., 1992; Nguyen et al., 2005; Nyström et al., 2005; Roperch et al., 2008; Van Aken et al., 2004; Vleminckx et al., 1991) . Although it may be impossible to achieve a general standardization of collagen type I invasion models and analysis for all experimental settings, the easy-handling protocols presented herein for single cell and spheroid invasion models, and morphometric analysis are designed to encourage scientists and the pharmaceutical industry to consider (collagen type I) invasion models as part of the standard repertoire for drug evaluation.
Experimental Protocols (I -Reagents, Equipment)

Reagents
The lists provided in this section are based on the materials used in our laboratory. Chemicals and cell culture materials may be purchased from other distributors and/or manufacturers. -Dulbecco's modified eagle medium (DMEM; Invitrogen cat.no.
41965-039). Store at 4°C. -FBS (Greiner cat.no. 758093S5595) Long time storage at -20°C, short term at 4°C. CRITICAL: Serum quality affects single-cell and spheroid formation and should be routinely tested! -Penicillin/streptomycin 10,000 U pen./10mg strep. ml -1 (Invitrogen cat.no. 15140163 
Reagent setup
Standard medium DMEM with phenol red containing 4.5g liter -1 D-glucose, 1% (wt/ vol) L-glutamine and without sodium pyruvate, supplemented with 100U ml -1 penicillin, 100mg ml -1 streptomycin and 10% FBS is used as standard medium for routine cell and spheroid culturing and preparation of collagen gels. Standard medium can be stored at 4°C for up to 2 weeks.
Drugs for preclinical validation (e.g. gefitinib)
Prepare appropriate stock solutions of drugs and store at conditions required to keep optimal drug activity. For most but not all drugs in our laboratory, 100mM stock solutions in DMSO and storage at -20°C are suitable. Final DMSO concentrations in the collagen invasion assays of <0.2% are not expected to affect cancer invasion. Minor effects may already be seen at a concentration of 0.2-1%, depending on the cell type and culture condition. A proportion of >1% DMSO in the drug dilution for treatment should be avoided. Other solvents are to be verified. Individual solvent controls for each drug concentration may be considered.
0.25M Sodium bicarbonate
Dissolve 2.2g of sodium bicarbonate in 100ml of CMF-HBSS. Stir until the solution becomes clear, store at 4°C.
1M Sodium hydroxide
Dissolve 4g of sodium hydroxide in 100ml of CMF-HBSS. Stir until the solution becomes clear, store at 4°C.
Human recombinant TGF-α
Add 1ml of sterile PBS containing 0.1%BSA to a vial containing 0.1mg of TGF-α. This makes a a stock solution of 100μg ml -1 . Prepare 50 μl aliquots and store at -20°C for up to 6 months.
3% paraformaldehyde
Dissolve 3g of paraformaldehyde in PBS and adjust the volume to 100ml of PBS, heat the mixture to 80°C, stir until the solution becomes clear, add 10μl 1MCaCl 2 and 10μl 1M MgCl 2 and cool to room temperature and check that the pH=7.4. Filter through a 0.45μm filter and use immediately or store aliquots in dark glass bottles in -20°C. Thawed paraformaldehyde should be warmed to at least room temperature or preferable 37°C, discard remaining solution after thawing.
CAUTION Paraformaldehyde is toxic. Work under the hood and use gloves.
2%BSA/1%glycine in PBS
Dissolve 2g BSA and 1g glycine in PBS and adjust the volume to 100ml of PBS, stir until the solution becomes clear, store at 4°C.
0.5% Triton X-100 solution
Add 500 μl of Triton X-100 to 100ml of PBS.
Experimental Protocols (II -Equipment Setup)
Cancer cell lines Various cancer cell lines of different origin are subjected to the collagen invasion protocol ( Table 1 ). All of these lines are commercially available (except HCT-8/E11 which is an epithelial subclone from HCT-8 (Vermeulen et al., 1995) ; the HCT-8/E11 cell line is available from our laboratory upon request). Not all of these can be applied in a spheroid-based screen (Friedrich et al., 2009 
Stromal myofibroblast primary cultures
Isolate primary human colon tumor-derived myofibroblast cells from tumor explants (De Wever et al., 2004a; 2004b) . Myofibroblasts at passages >2 and <8 are most suitable for use in the heterotypic spheroid invasion model. Use standard medium for routine culturing. Keep cultures in humidified atmosphere with 10% CO 2 in air at 37°C.
Image processing
Sample preparation, optical microscopy observations and image caption conditions must be carefully established in order to achieve optimal image quality, i.e., a maximum contrast between the sample and the background. However, in some cases, experimental conditions prevent, to fulfill completely this requirement. For example, if the single-cells or spheroids are placed at the border of the support, uneven illumination could generate a dark rim on both sides of the image.
Process and quantify the digital images (300 pixels inch -1 ) using ImageJ software. Change the image to 8-bit type. Use the threshold function to convert areas of interest to saturated black areas in a uniform manner to have a binary (black&white) image. In a next step, subject the binary image to two 'clean-up' procedures: exclude all particles less than three pixels in size and remove any artifacts by comparing the binary image to the phasecontrast or phase-contrast-GFP fluorescence pictures. Use the set measurements dialog box to specify area and perimeter. Use the analyze particle dialog box to measure all particles and to generate a "particle report" for each image in which the area and perimeter of individual particles and the area of the sum of individual particles is documented. The area calculated as number of pixels is defined as invasion-area in the single-cell invasion 
MORPHOTYPE ANALYSIS OF TISSUE CULTURE PLASTIC SUBSTRATE AND SINGLE CELL INVASION INTO COLLAGEN TYPE I OF 15 COMMERCIALLY AVAILABLE HUMAN CANCER CELL LINES
E, epitheloid; F, fibroblastic; M, Mixed; -, 0-4.9%; +, 5-9.9%; ++, 10-14,9%; +++, >15% assay and as area in the heterotypic spheroid invasion assay. The mean invasion area or area is indicated +/-standard error mean. The shape factor refers to a value that is affected by an object's shape but is independent of its dimensions. Calculate the factor shape from Image J binarized F-actin stainings using the following formula (perimeter) 2 /4π(area) where perimeter = 2πR and area=πR 2 . It gives a minimal value of 1 for a perfect circle and larger values for shapes having a higher ratio of perimeter to area (Pinner and Sahai, 2008) . The mean factor shape of 30 singlecells or 20 spheroids is indicated +/-standard error mean. The percent fragmentation, used in the heterotypic spheroid invasion model, is calculated as the percent of single or clustered cells released from the total spheroid area. The mean percent fragmentation of 20 spheroids is indicated +/-standard error mean.
Statistics
Perform Chi-Square test for group comparison in the singlecell collagen invasion model when counting the number of noninvasive and invasive cells in 10 microscopic fields.
Use Mann Whitney test when comparing invasion area in the single cell collagen invasion model and factor shape in both invasion models.
Analyze the area data in the heterotypic spheroid collagen invasion model by repeated measures analysis of variance with testing of the equality of variances. Use the Tukey's test for post hoc contrasts.
Experimental Protocols (III -Procedure)
Single-cell collagen invasion model
For schematic see Fig. 1 .
Preparation of a collagen gel: Working time 30min
, incubation time at least 1h 1) Prepare collagen type I solution with a final concentration of 1 mg ml -1 collagen type I by mixing the following precooled (stored at 4 °C) components: 4 volumes collagen type I (stock is 3.49 mg ml -1 ), 5 volumes of CMF-HBSS, 1 volume of MEM (10x), 1 volume of 0.25M NaHCO3, 2.65 volumes of standard medium and 0.3 volumes of 1M NaOH to make the solution alkaline. CRITICAL: Mix gently by pipetting, avoiding the introduction of air bubbles. Keep the solution on melting ice. The final solution should look purple due to the phenol red pH indicator showing a pH>9. The concentration of the stock collagen type I is variable. Adapt volume of collagen type I with CMF-HBSS if necessary. Volumes of MEM, NaHCO3, standard medium and NaOH remain constant. If necessary, you may increase concentration of collagen type I up to 2mg ml -1 . TIMING: Collagen type I solution can be stored at 4°C for up to two weeks. TROUBLESHOOTING advice can be found in Table 2 .
2) Add, for each test-condition, 1.25ml of collagen type I solution to one well of a 6-well plate, spread homogeneously and let gelify on a flat surface in a humidified atmosphere of 10% CO 2 in air at 37°C for at least 1h to obtain a collagen gel with a 250 μm central thickness in the well. CRITICAL: Avoid introduction of air bubbles. Monitor the polymerization of the collagen gel carefully before starting step 5-6. TIMING: You may keep collagen type I gels up to 24h in a humidified atmosphere of 10% CO 2 in air at 37°C. SUGGESTION: You may add the testing products in collagen type I solution. TROUBLESHOOTING advice can be found in Table 2 .
Preparation of single-cells: Working time 30min
Perform step 3-5 during gelification time of collagen.
3) Prepare a single-cell suspension in standard medium by mild enzymatic dissociation, using a Ca 2+ -and Mg 2+ -free PBS wash followed by incubation with a trypsin/EDTA solution, of an exponentially growing culture (usually 70% confluence is used). CRITICAL: Optimize trypsinization procedure for every cell type. It is essential to inactivate trypsin and to remove EDTA after trypsin/EDTA procedure. Trypsin inhibition is accomplished by trypsin inhibitors in the serum in the standard medium. Therefore, dilute the suspended cells with 5ml of standard medium and pellet by centrifugation. Aspirate the supernatant, and resuspend the cells in 5ml of standard medium. Repeat this procedure twice. Avoid cell doublets and clusters by filtering the cell suspensions through 30-35μm sterile meshes or fine needle aspiration (especially when using strongly adherent cell lines such as HCT-8/E11, MCF7 and HT-29). Avoid repeated dissociation of cell cultures within less than 2 d. 4) Count a small aliquot of the cell suspension after staining with Trypan blue (0.04% Trypan blue in PBS) to exclude dead cells.
Initiation of invasion model: Working time 30 min for 6 conditions
5) Prepare 1-2x10 5 viable, single-cells in 1ml standard medium in 15ml polypropylene tubes. Add test products such as growth factors (TGF-α) or drugs for preclinical (gefitinib) validation in desired concentration. Gently seed this mixture on top of blindcoded collagen type I gels. CRITICAL: Avoid high pressure seeding of the cell suspension, it may damage the collagen gel. Use left-right and forward-backward movement of the 6-well plate to make sure the cells are evenly distributed over the whole gel surface. TROUBLESHOOTING advice can be found in Table 2. 6) Incubate cells in a humidified atmosphere with 10% CO 2 in Table 2. 8) Take a digital image from 10-15 microscope fields.
Calculation of invasion index (manual cell counting):
Working time 1h for 6 conditions 9) Calculate the invasion index (cells with invasive extensions versus total number of cells x 100) by manual counting the number of invading and non-invading cells present in 10-15 microscope fields. Results can be plotted as depicted in Fig. 2 .
Calculation of invasion area (digital analysis): Working time 3h for 6 conditions
10) Process image into a binary image to allow computerized quantification of the invasive extensions. This implicates a two step process. Fig. 2 shows a raw binary image that includes invasive cellular extensions and binary artefacts such as collagen fibers and intracellular structures. Finally, logical subtraction allows to identify the invasive cellular extensions (Fig.  2) . The mean invasion area from 10-15 microscopy fields can be calculated by counting the pixel number (Fig. 2) .
Evaluation of F-actin cytoskeleton organization: Working time 2h for 6 conditions 11) Fix collagen matrices for 20 min with 3% paraformaldehyde in PBS at room temperature. TIMING: Fixed matrices can be kept in PBS at 4°C for 2 weeks. 12) Remove a 1cm 2 surface by scalpel and forceps from the middle of the collagen gel. TROUBLESHOOTING advice can be found in Table 2. 13) Permeabilize collagen gels for 15 min with 0.5%Triton X-100 in PBS and block for 30 min with 2%BSA/1%glycine in PBS (Denys et al., 2008) . Incubate samples for 30min at 37°C with Alexa Fluor 488 or 594 conjugated phalloidin, followed by extensive washing and mounting. CRITICAL: Always keep samples in the dark when using fluor dye conjugated phalloidin. Solidify mounting medium on a cold plate. Fix edges of cover glass with nailpolish to avoid movement during microscopy.
14) Cells are imaged by confocal laser-scanning microscopy using a 488 argon or a 543 HeNe laser. Images are acquired using a Plan NeoFluar 40X/1 lens. 
Heterotypic spheroid collagen invasion model
For schematic see Fig. 3 .
Spheroid initiation: Working time 1h
1) Prepare a single-cell suspension (see step 3 single-cell invasion model). CRITICAL: Use cancer cells transfected with reporters such as GFP or DsRed for optimal contrast between cancer cell spheroid and collagen gel during image analysis.
2) To initiate compact spheroids of 150-μm diameter at day 3 after inoculation, dilute dissociated cells to appropriate concentrations in 6ml standard medium, e.g. 2x10 5 cells ml -1 for HCT-8/E11-GFP human colon cancer cells, in a 50-ml Erlenmeyer flask. This cell number is sufficient to obtain +/-100 compact spheroids of 150-μm diameter. CRITICAL: For each cancer cell line, the cell number that is needed to create spheroids of +/-150 μm in diameter at day 3 after initiation has to be determined empirically (Friedrich et al., 2009 ). In our setup, compact spheroid formation is routinely checked by individual microscopic evaluation for cell concentrations ranging from 5x10 4 to 5x10 5 cells ml -1 . TROUBLESHOOTING advice can be found in Table 3. 3) Incubate Erlenmeyer flasks for 72 h on a Gyrotory shaker at 37°C and 70 rpm in humidified atmosphere with 10% CO 2 in air. TROUBLESHOOTING advice can be found in Table 3 . 4) After 72 h of incubation (day 3 after initiation of spheroids) control sphericity and compaction of spheroids by individual microscopic monitoring (x-y-z direction). If spheroids are spheric and compacted proceed with step 7. CRITICAL: Avoid precipitation and/or attachment of spheroids on glass substrate. Replace Erlenmeyer containing spheroids on a Gyrotory shaker at 37°C and 70 rpm in humidified atmosphere with 10% CO 2 in air, when quality control is microscopically evaluated. TROUBLESHOOTING advice can be found in Table 3 .
Preparation of collagen type I bottom gellayer (eventually containing stromal cell population): Working time 30min, incubation time 1h
5) Prepare a single-cell suspension from primary myofibroblasts cultured in standard medium by mild enzymatic dissociation, using a Ca 2+ -and Mg 2+ -free PBS wash followed by incubation with a trypsin/EDTA solution (usually 70% confluence is used). CRITICAL See step 3 single-cell collagen invasion model. 6) Prepare collagen type I solution (see step 1 of single-cell collagen invasion model).
7) Prepare 1x10 6 viable, single myofibroblasts in 1.25ml collagen type I solution and pour gently in a well of 6-well plate. For control use 1.25ml of collagen type I solution without myofibroblasts. CRITICAL: Use left-right and forward-backward movement of the 6-well plate to make sure the cells are evenly distributed in the whole gel solution.
8) Incubate collagen gels in a humidified atmosphere with 10% CO 2 in air at 37°C for 1h.
Preparation of spheroid-containing collagen type I gellayer: Working time 1h, incubation time 1h
Perform step 9-10 during gelification time of bottom collagen type I layer. 9) Transfer approximately 20 spheroids (a volume of 1.20ml) in a 15ml polypropylene tube. Let the spheroids sediment through gravitation. CRITICAL: Do not centrifuge spheroids, they may stick together to form one large aggregate. 10) Discard the supernatant and add 1.25ml of collagen type I solution. Mix gently, avoid the introduction of air bubbles and pour gently onto existing collagen type I layer. CRITICAL: Avoid high shear stress by pipetting, it may damage-desintigrate the spheroids. Use left-right and forwardbackward movement of the 6-well plate to make sure the spheroids are evenly distributed in the whole gel solution. TROUBLESHOOTING advice can be found in Table 3 .
Step 11) Incubate in a humidified atmosphere with 10% CO 2 in air at 37°C for 1h to allow gelification of collagen solution. TROUBLESHOOTING advice can be found in Table 3. 12) Code all individual spheroids by numbering them with a pen on the bottom of the well plate. Add 2 ml of standard medium, refresh every 48h and incubate in a humidified atmosphere with 10% CO 2 in air at 37°C. CRITICAL: Avoid high pressure addition (and exchange) of standard medium, it may damage the collagen gel. Avoid aspiration of medium but gently remove medium by pipetting. TROUBLESHOOTING advice can be found in Table 3 .
Evaluation of spheroid invasion: Working time 1h per condition, every day over a period of 4 days
13) Collect phase-contrast GFP images of all individual spheroids at start of incubation and every 24h thereafter e.g., on a Zeiss Axiovert 200 with objective 10x equipped with camera system.
Calculation of area, factor shape, and percentage fragmentation by digital analysis: Working time 1h for 20 images 14) Process phase-contrast GFP images into a binary image to allow computerized quantification. Analyse the number of pixels and calculate the mean area and perimeter of 20 spheroids by Image J (Fig. 4B and 4D ). Calculate factor shape and percentage fragmentation (Fig. 4C) .
Evaluation of F-actin cytoskeleton organization: Working time 1h for 2 conditions
See step 11-14 in single-cell collagen invasion model.
Results and Discussion
Single-cell collagen invasion model
Critical to the integration of the single-cell collagen invasion model into testing protocols of pro-or antiinvasive compounds is the selection of suitable cell lines. Therefore, 15 established, commercially available human cancer cell lines derived from different tumor types are characterized for their morphotype on tissue culture substrate and single-cell invasion into collagen type I (Table 1) . For example, HCT-8/E11 cells seeded on top of collagen type I gels, mostly attach as round cells on the collagen with the appearance of a bright halo when cells are in phase (Fig. 2) . Oc- (Rodrigues et al., 2003) . As expected, HCT-8/E11 cells supplemented with TGF-α show a tremendous change in morphotype. When TGF-α-treated HCT-8/E11 cells are in phase, multiple cells show a bright halo with dark, cellular extensions (Fig. 2 ) that are out of phase and actually located inside the collagen matrix. Treatment with TGF-α stimulates the invasive potential of HCT-8/E11 cells in a dose-dependent manner (Chi Square test; 1ng ml -1 , P=0.3524; 10ng ml -1 , P=0.000283; 100ng ml -1 , P<0.0001) (Fig.  2) . Accordingly, a clinically approved inhibitor of the EGF receptor, gefitinib, abrogates the TGF-α-stimulated invasion in a dosedependent manner (Chi Square test; 10ng ml -1 TGF-α combined with 0.1 μM gefitinib, P=0.14; 10ng ml -1 TGF-α combined with 1 μM gefitinib, P=0.72). Alternatively to manual cell counting, binary image processing allows computerized quantification of the invasive extensions (Fig. 2) . The mean invasion area can be calculated by counting the pixel number of the dark-appearing cellular extensions (Fig. 2) , which is significantly higher when HCT-8/E11 cells are supplemented with increasing concentrations of TGF-α (Mann Whitney test; 1ng ml -1 , P=0.3335; 10ng ml -1 , P=0.000134; 100ng ml -1 , P<0.0001). As expected, gefitinib blocked TGF-α stimulated invasion (Mann Whitney test; 10ng ml -1 TGF-α combined with 0.1 μM gefitinib, P=0.09; 10ng ml -1 TGF-α combined with 1 μM gefitinib, P=0.56). Cell viability check by Trypan blue exclusion at the end of the experiment showed that this inhibitor did not exert a toxic effect (not shown). The standard deviation of HCT-8/E11 single-cell invasion is reproducibly below 10% between different experiments. Subsequently, the effect of TGF-α on organisation of the F-actin cytoskeleton is investigated on individual HCT-8/E11 cells (Fig. 2) . Approximately 99% of control cells have a rounded morphology with prominent cortical (associated with plasmamembrane) F-actin and membrane blebs. Addition of TGF-α disrupts the cortical F-actin in many cells and produces a more elongated cell morphology with multiple long protrusions. In agreement, the factor shape for control cells has a mean of 1.6 +/-0.6, indicating that they are generally rounded, whereas TGF-α treated cells have increased mean values of 5.9 +/-1.3 (Mann Whitney test; P<0.0001).
Heterotypic spheroid collagen invasion model
A possible disadvantage of the single-cell invasion assay is that it lacks structural architecture and that the cells are added under a mono-dispersed state. The multicellular spheroid system is much more adapted to study invasion mechanisms taking into account homotypic cell-cell contacts. The spheroid invasion model also reproduces some aspects of the restrictions in cellular growth and viability observed in growing tumors in vivo. Growing spheroids in vitro mimick growing tumors in vivo and their associated progressive deprivation in oxygen (hypoxia), nutrients, growth factors as well as limitations in the penetration and action of drugs. According to literature data, it is expected to identify drug candidates with less therapeutic efficacy in the heterotypic spheroid invasion model (Friedrich et al., 2009) . Furthermore, a stromal-derived 50-gene signature predicts resistance to preoperative chemotherapy (5 fluorouracil, epirubicin, cyclophosphamide) in estrogen receptornegative breast cancer (Farmer et al., 2009) . Here, co-culture spheroids will be a tool for negative selection and could (i) contribute significantly to a reduction in animal testings and thus to economical savings and (ii) also become a powerful model to optimize drug candidates for enhanced efficacy. Conversely, there is also experimental evidence that some drugs may exclusively be effective in three-dimensional but not two-dimensional culture, as has been seen in some target-specific treatment modalities, often with the molecular target being expressed only or particularly in a three-dimensional environment (Wang et al., 2002) . The co-culture setup of colon cancer cells with colon tumor-derived myofibroblasts in the heterotypic spheroid invasion model allows for investigation of the intimate cellular and molecular cross-signaling between tumor-associated host cells and cancer cells. A representative phase contrast-GFP picture of one HCT-8/E11-GFP spheroid is shown at different time intervals (Fig. 4A) . Under control conditions it is obvious that the cancer cell spheroid increases in volume over time but remains shaped as a compact spheric structure. In sharp contrast, the cancer cell spheroid in co-culture with human colon myofibroblasts has a robust increase in volume, is irregularly shaped at the surface circumference, and is fragmented. The cross-signaling with myofibroblasts induces an invasive growth program in HCT-8/E11 colon cancer cells. This invasive growth program (Fig. 4B) is characterized by the factor shape, the percent fragmentation and the mean area calculated from 20 spheroids at each time point. The factor shape has a mean value of 1.3+/-0.2 at time 0h indicating the circularity. Under control conditions this value reaches a maximum mean value of 2.84+/-0.4 at time 96h, still indicating that the spheroid shape is generally retained (Fig.  4C) . Under co-culture conditions this value reaches a maximum mean value of 9.41+/-0.85 at time 96h (Mann Whitney test; P=0.000347), indicating the irregular, infiltrating shape of the spheroid. The percent fragmentation remains lower than 1% under control conditions and does not vary with time (Fig. 4C) . However, starting after 48h of heterotypic signalling with myofibroblasts, fragmentation is 3-fold stimulated and this fragmentation remains persistent. The size of the patterned spheroid structure is calculated as mean area and is significantly higher starting 24h after coculture with myofibroblasts as shown in Fig. 4D (repeated measures ANOVA test, P<0.001).
Perhaps the most challenging aspect of complex co-culture studies is to define the phenotypic composition of the growing spheroids. Phenotyping with specific molecular markers, e.g., for cell-cell adhesion (E-cadherin), proliferation (Ki-67), apoptosis (TUNEL) and motility (F-actin), could be done by conventional immuno-histochemical methods on paraffin sections and 3D staining by confocal microscopy in order to connect phenotypes and their relative dominance with tumor morphology. Investigation of the F-actin organization by confocal microcopy reveals that the control spheroids are smoothly edged with occasional formation of invasive extensions (Fig. 4E) . However, in the myofibroblast coculture the spheroid structure has a rough surface and shows fragmented cells inside the collagen matrix. This roughness re- flects invasive morphology and can be clearly appreciated by the confocal images of the F-actin staining.
In order to translate the findings from basic cellular research into clinical applications, cell-based models need to recapitulate both the three-dimensional organization and multicellular complexity of an organ but at the same time accommodate systematic experimental intervention. The invasion models, presented here, consist of native collagen type I containing nonhelical telopeptides situated at the N-and C-terminal ends. These telopeptides play an important role in intermolecular covalent cross-links necessary for a gel architecture presenting itself as a structural barrier to cancer cell traffic (Sabeh et al., 2009 ). These systems allow (i) analysis of pro-/anti-invasive compounds, (ii) analysis of gene dosage/knock down on invasion, (iii) identification of specific mechanisms that underlie invasion, (iv) and analysis of the impact of the stromal environment on cancer invasion. Furthermore, the complementary assays are membrane-free and preserve cell morphology, allow real-time monitoring, have a kinetic flexibility and are highly reproducible. For example, in Transwell ® chemoinvasion assays where cancer cells invade through a polycarbonate filter coated with a matrix substrate toward a chemoattractant, the number of cells crossing the filter can be counted at various time points. However, when invaded cells attach to the underside of the polycarbonate filter the possibility to perform morphotypic and morphometric analysis is greatly compromised. The collagen invasion models in combination with computerized quantification and powerful cell-pattern-recognition software are cost-effective and offer unprecedented potential for gaining new insights into cancer cell invasion. In support of this, a multiscale mathematical model of cancer invasion, which considers cellular and microenvironmental factors simultaneously and interactively, was developed to provide a theoretical and experimental framework to quantitatively characterize selective pressure for invasion (Anderson et al., 2006) . The collagen invasion models, though not and exact replication of the in vivo environment, have many obvious applications especially in cancer research but also in tissue engineering and regenerative medicine (Narine et al., 2006) .
